Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • Clinical Oncology
      • Immuno-oncology
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
    • Journal Press Releases
Research Articles

Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy

Courtney H. Coschi, Charles A. Ishak, David Gallo, Aren Marshall, Srikanth Talluri, Jianxin Wang, Matthew J. Cecchini, Alison L. Martens, Vanessa Percy, Ian Welch, Paul C. Boutros, Grant W. Brown and Frederick A. Dick
Courtney H. Coschi
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles A. Ishak
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Gallo
Biochemistry,Donnelly Centre, University of Toronto; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aren Marshall
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srikanth Talluri
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianxin Wang
Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. Cecchini
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison L. Martens
Authors' Affiliations:London Regional Cancer Program;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Percy
Authors' Affiliations:London Regional Cancer Program;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Welch
Veterinary Services, Western University, London; Departments of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul C. Boutros
Medical Biophysics, andPharmacology and Toxicology,Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grant W. Brown
Biochemistry,Donnelly Centre, University of Toronto; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick A. Dick
Authors' Affiliations:London Regional Cancer Program;Children's Health Research Institute;Department of Biochemistry, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fdick@uwo.ca
DOI: 10.1158/2159-8290.CD-14-0215 Published July 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Rb1-mutant MEFs exhibit increased γH2AX foci that are enriched at pericentromeric DNA. A, immunofluorescence microscopy of γH2AX staining is shown in red and cells were counterstained with 4′,6-diamidino-2-phenylindole (DAPI; blue). Red arrows, colocalization; white arrows, lack of colocalization; scale bars, 10 μm. B, the quantity of foci per cell was determined for each genotype and compared using a χ2 test. Rb1+/+, n = 103; Rb1ΔL/ΔL, n = 114; Rb1−/−, n = 63. C, the proportion of cells with γH2AX foci colocalizing with DAPI-rich foci was determined by confocal 3D rendering and compared using a χ2 test. D, ChIP-seq analysis was performed for γH2AX, and tracks comparing abundance at Fra16d among different Rb1 genotypes are shown. A red box indicates this locus on a chromosome 8 ideogram. E, heatmap to show log2 ratios of the abundance of Rb1-mutant γH2AX precipitable reads per million mapped reads versus wild-type γH2AX precipitated reads. ERV, endogenous retrovirus. F and G, ChIP-qPCR for γH2AX to quantitate major satellite (major sat.) repeats. *, P < 0.05 using a t test; n = 3.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Replication abnormalities in Rb1-mutant cells. A, fluorescence microscopy of a replicating fork is shown by CIdUrd labeling (P1, green) and IdUrd (P2, red), and light blue bars mark unlabeled DNA. B, fork rates were measured for Rb1+/+ (n = 718) and Rb1ΔL/ΔL (n = 855). Median values werecompared using the Mann–Whitney U test. C, diverging forks, as shown in A, were measured and the percentage asymmetry was determined, Rb1+/+ (n = 141) and Rb1ΔL/ΔL (n = 174). Median values were compared as in B. D, extracts were blotted for RPA and the indicated phosphorylated RPA-S33. Relative intensity of RPA pS33 is shown below each lane. E, ChIP-qPCR analysis of RPA at major satellite repeats in Rb1+/+ and Rb1ΔL/ΔL MEFs. *, P < 0.05 using a t test; n = 3. F–H, ChIP-qPCR analysis of PCNA, MCM3, and DNA Polδ occupancy at major satellites.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    pRB, E2F1, and Condensin II localize to pericentromeric DNA. A, ChIP-qPCR for major satellite repeats using antibodies against pRB and CAP-D3. *, P < 0.05 using a t test; n = 3. B, chromatin was precipitated with E2F1 and CAP-D3 antibodies and major satellite repeats were amplified. C, ChIP-qPCR using a CAP-D3 antibody to precipitate major satellite repeats in Rb1+/+, Rb1−/−, and Rb1ΔL/ΔL MEFs. D, ChIP-seq was performed for CAP-D3 using chromatin from Rb1+/+ and Rb1ΔL/ΔL MEFs and tracks are shown for selected genomic regions. E2F binding sites present in the promoters of Ccne1, Mcm3, and Rbl1 are indicated by red boxes, and regions of significant enrichment (MACS peaks) are indicated in green.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    pRB, E2F1, and Condensin II form a complex on pericentromeric DNA. A, nuclear extracts (NE) were mixed with streptavidin beads and a biotinylated major satellite (maj. sat.) repeat containing probe. Precipitated proteins were analyzed by SDS-PAGE and Western blotting. B, wild-type nuclear extracts were mixed with the indicated probes and/or competitor DNA. C, RB1-deficient C33A cells were transfected with HA-E2F1 and HA-DP1 expression vectors and nuclear extracts were prepared. Western blots of relevant proteins are shown. D, nuclear extracts were mixed with streptavidin beads and biotinylated major satellite probes, either with or without GST-RBLP. Associated proteins were precipitated and analyzed by Western blotting. E and F, ChIP-qPCR for E2F1 was performed, and major satellite repeat DNA was amplified by real-time PCR. *, P < 0.05 using a t test; n = 3. F, ChIP-qPCR using a CAP-D3 antibody was performed to precipitate major satellite repeats from Rb1+/+, Rb1ΔG/ΔG, and Rb1ΔS/ΔS MEFs.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Rb1 heterozygous MEFs have elevated γH2AX and underloading of CAP-D3 at major satellites. A, immunofluorescence microscopy of γH2AX staining in Rb1+/+, Rb1ΔL/+, and Rb1+/− MEFs is shown. Scale bars, 10 µm. B, the quantity of γH2AX foci per cell was determined for Rb1+/+, Rb1ΔL/+, and Rb1+/− MEFs and compared with homozygous mutants from Fig. 1. The quantity of foci was compared using a χ2 test. Rb1ΔL/+, n = 114; Rb1+/−, n = 63. C, quantification of DAPI foci colocalization with γH2AX foci by confocal microscopy. The proportion of colocalization was compared using a χ2 test. D, γH2AX levels were detected by Western blotting and Coomassie staining of histones was used as a loading control. Relative intensity of γH2AX is shown below. E, RPA32 and RPA32 phospho serine 33 levels were detected by Western blotting. Relative intensity of RPA pS33 is shown below. F, heatmap depicting log2 ratios of γH2AX precipitated sequence tags in the indicated mutants relative to wild-type control. G, ChIP-qPCR using a CAP-D3 antibody in Rb1+/+ and Rb1ΔL/+ MEFs was used to detect major satellite repeats. *, P < 0.05 using a t test; n = 3.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Normal RB1+/− cells have elevated γH2AX foci, mitotic errors, and aneuploidy. A, immunofluorescence microscopy for γH2AX in control and RB1+/− patient fibroblasts. Scale bars, 10 μm. B, quantitation of γH2AX foci in control and each patient fibroblast isolate. Foci were compared for patient fibroblasts against pooled control data (IMR90, BJ, and WI-38) using a χ2 test. Pooled control, n = 246; GM_01408, n = 79; GM_01123, n = 93; GM_06418, n = 71. C, Western blotting was used to detect phosphorylated RPA pS33 and total RPA32. Relative intensity of RPA pS33 is displayed. D, cells were transduced with H2B-GFP, and video microscopy was performed to capture phase contrast and GFP images over 15 hours. The left-most image shows the onset of prophase, and the middle image is of the metaphase plate just before the onset of anaphase (elapsed time since the onset of prophase is shown in yellow). The right-most image shows cells in telophase. Scale bars, 50 μm. E, summary of video microscopy data showing the number of divisions observed along with the number that contained anaphase bridges. Similarly, the number of cells observed to complete prophase and metaphase is shown along with the average length of these two phases. Each patient fibroblast is compared with pooled control data. #, P < 0.05, χ2 test; †, P < 0.05, t test. F–I, quantitation of genomic abnormalities in mesenchymal-derived cancer cell lines that are wild-type (n = 15), hemizygous (n = 10), or null (n = 12) for RB1. Means were compared using a t test. *, P < 0.05. NS, not significant.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Haploinsufficiency of Rb1 contributes to aneuploidy. A, Kaplan–Meier survival proportions are shown for Rb1ΔL/+;Trp53−/− mice (n = 52). Previously reported data for Rb1ΔL/ΔL;Trp53−/− and Trp53−/− mice is included as a comparison. Asterisks indicate populations that are significantly different from the Trp53−/− control (log-rank test, P < 0.05). B, Rb1 tumor genotypes (Tu) were determined by PCR; matched tail DNA (T) is shown as a comparison. C, representative images of H&E-stained tumors from Trp53−/− control, Rb1ΔL/ΔL;Trp53−/−, and Rb1ΔL/+;Trp53−/− compound mutants. Scale bars, 100 μm. D, control, or tumor DNA, was used for array comparative genomic hybridization (CGH). Representative graphs show log2 ratio values plotted against chromosome number. Individual chromosomes are shown in different colors. E, whole-chromosome changes (among autosomes) for Rb1ΔL/+;Trp53−/− tumors is plotted against their genotype. Previously reported control, Trp53−/−, and Rb1ΔL/ΔL;Trp53−/− data are shown for comparison. The control male versus control male hybridization is shown in blue; the male versus female hybridizations are shown in yellow. The means were compared between genotypes using a t test, *, P < 0.05. NS, not significant.

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Methods - PDF file 125K, Detailed methods for ChIP, microscopy, and computational analysis. Lists of cell lines and antibodies used are included
    • Supplementary Figure Legends - PDF fie 148K, Description of additional genotypes of cells analyzed for gammaH2AX distribution and detailed instability phenotypes of heterozygous cells
    • Supplementary Figures - PDF file 3766K, Analysis of gammaH2AX distribution, chromosomal instability phenotypes in heterozygous cells, and verification of genotypes in human cells
PreviousNext
Back to top
Cancer Discovery: 4 (7)
July 2014
Volume 4, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
Courtney H. Coschi, Charles A. Ishak, David Gallo, Aren Marshall, Srikanth Talluri, Jianxin Wang, Matthew J. Cecchini, Alison L. Martens, Vanessa Percy, Ian Welch, Paul C. Boutros, Grant W. Brown and Frederick A. Dick
Cancer Discov July 1 2014 (4) (7) 840-853; DOI: 10.1158/2159-8290.CD-14-0215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Haploinsufficiency of an RB–E2F1–Condensin II Complex Leads to Aberrant Replication and Aneuploidy
Courtney H. Coschi, Charles A. Ishak, David Gallo, Aren Marshall, Srikanth Talluri, Jianxin Wang, Matthew J. Cecchini, Alison L. Martens, Vanessa Percy, Ian Welch, Paul C. Boutros, Grant W. Brown and Frederick A. Dick
Cancer Discov July 1 2014 (4) (7) 840-853; DOI: 10.1158/2159-8290.CD-14-0215
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Methods
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • TBK1 is a novel therapeutic target in cancer with VHL loss
  • Characterization of TGFB-activated LRRC15+ CAFs in PDAC
  • MAIT cells promote tumor initiation, growth and metastases
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement